GoodRx Holdings, Inc. (GDRX) Tops Q4 EPS by 2c

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q4 EPS of $0.07, $0.02 better than the analyst estimate of $0.05. Revenue for the quarter came in at $184.1 million versus the consensus estimate of $178.67 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Q1 EPS miss sends shares down 9% after-hours
• Worthington Industries (WOR) Misses Q4 EPS by 9c